Abstract Introduction: Adrenocortical carcinomas (ACCs) are rare and aggressive cancers.
Approximately 60% of ACCs are functional, presenting with Cushing syndrome and/or …

Abstract Introduction: Adrenocortical carcinomas (ACCs) are rare and aggressive cancers.
Approximately 60% of ACCs are functional, presenting with Cushing syndrome and/or …

Background: Adrenocortical carcinomas (ACC) are rare malignancy with an incidence of 0.7-
2 per million population per year. While~ 60% of ACC are functional, clinical manifestations …

Background Adrenocortical carcinoma is a rare malignancy and rare cause of Cushing's
syndrome. Case presentation A 65-year-old seemingly well male patient was referred to our …

We report a case of a 22-year-old female with pedal edema, hypokalemia, and
hypertension. On suspicion of hyperaldosteronism, further workup was pursued, which only …

We report a case of a 22-year-old female with pedal edema, hypokalemia, and
hypertension. On suspicion of hyperaldosteronism, further workup was pursued, which only …

Adrenocortical carcinoma (ACC) is a rare malignancy that usually is detected as a result of
symptoms of hormone excess or mass effect. We describe a rare presentation of ACC with …

Primary adrenocortical carcinoma is a rare tumor, and is characterized by a peri-tumor mass
effect and hormone excess signs. Adrenocortical carcinoma most commonly secretes …

Adrenocortical carcinoma (ACC) is reported to be present in 3–10% of the population with
most tumors presenting as benign tumors. Most cases of ACC are a sporadic accumulation …

Discussion Immature steroidogenesis typically predominates over the production of terminal
pathway hormones in functional ACCs, particularly as the cancer progresses. This is the first …